Trofinetide Receives FDA Approval as First Drug for Rett Syndrome

Saved in:
Bibliographic Details
Published inJAMA : the journal of the American Medical Association Vol. 329; no. 14; p. 1142
Main Author Harris, Emily
Format Journal Article
LanguageEnglish
Published United States American Medical Association 11.04.2023
Subjects
Central Nervous System Agents - therapeutic use
Drug Approval
Glutamates - therapeutic use
Humans
Rett syndrome
Rett Syndrome - drug therapy
United States
United States Food and Drug Administration
United States
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2023.4003